These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30903580)

  • 1. Aerosolized Lipid Amphotericin B for Complementary Therapy and/or Secondary Prophylaxis in Patients with Invasive Pulmonary Aspergillosis: A Single-Center Experience.
    Venanzi E; Martín-Dávila P; López J; Maiz L; de la Pedrosa EG; Gioia F; Escudero R; Filigheddu E; Moreno S; Fortún J
    Mycopathologia; 2019 Apr; 184(2):239-250. PubMed ID: 30903580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosolised liposomal amphotericin B to prevent aspergillosis in acute myeloid leukaemia: Efficacy and cost effectiveness in real-life.
    Chong GL; Broekman F; Polinder S; Doorduijn JK; Lugtenburg PJ; Verbon A; Cornelissen JJ; Rijnders BJ
    Int J Antimicrob Agents; 2015 Jul; 46(1):82-7. PubMed ID: 25956843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized amphotericin B lipid complex and invasive pulmonary aspergillosis: a case report.
    Canetti D; Cazzadori A; Adami I; Lifrieri F; Cristino S; Concia E
    Infez Med; 2015 Mar; 23(1):44-7. PubMed ID: 25819050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolized amphotericin B as prophylaxis for invasive pulmonary aspergillosis: a meta-analysis.
    Xia D; Sun WK; Tan MM; Zhang M; Ding Y; Liu ZC; Su X; Shi Y
    Int J Infect Dis; 2015 Jan; 30():78-84. PubMed ID: 25461661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients.
    Husain S; Capitano B; Corcoran T; Studer SM; Crespo M; Johnson B; Pilewski JM; Shutt K; Pakstis DL; Zhang S; Carey ME; Paterson DL; McCurry KR; Venkataramanan R
    Transplantation; 2010 Dec; 90(11):1215-9. PubMed ID: 20881664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
    Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
    Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
    Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
    J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
    Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
    Kirkpatrick WR; Najvar LK; Vallor AC; Wiederhold NP; Bocanegra R; Pfeiffer J; Perkins K; Kugler AR; Sweeney TD; Patterson TF
    J Antimicrob Chemother; 2012 Apr; 67(4):970-6. PubMed ID: 22240402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients.
    Kamalaporn H; Leung K; Nagel M; Kittanakom S; Calvieri B; Reithmeier RA; Coates AL
    Pediatr Pulmonol; 2014 Jun; 49(6):574-80. PubMed ID: 23843366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
    Rijnders BJ; Cornelissen JJ; Slobbe L; Becker MJ; Doorduijn JK; Hop WC; Ruijgrok EJ; Löwenberg B; Vulto A; Lugtenburg PJ; de Marie S
    Clin Infect Dis; 2008 May; 46(9):1401-8. PubMed ID: 18419443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial.
    Slobbe L; Boersma E; Rijnders BJ
    Pulm Pharmacol Ther; 2008 Dec; 21(6):855-9. PubMed ID: 18951992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
    Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Ullmann AJ; Bouza E; Heussel CP; Lortholary O; Rieger C; Boehme A; Aoun M; Horst HA; Thiebaut A; Ruhnke M; Reichert D; Vianelli N; Krause SW; Olavarria E; Herbrecht R;
    Clin Infect Dis; 2007 May; 44(10):1289-97. PubMed ID: 17443465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled amphotericin B as fungal prophylaxis in heart transplant recipients.
    Wilde AM; Nailor MD
    Conn Med; 2011; 75(10):613-5. PubMed ID: 22216677
    [No Abstract]   [Full Text] [Related]  

  • 15. Aerosol and other novel administrations for prevention and treatment of invasive aspergillosis.
    Drew RH
    Med Mycol; 2009; 47 Suppl 1():S355-61. PubMed ID: 18654913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.
    Offner F; Krcmery V; Boogaerts M; Doyen C; Engelhard D; Ribaud P; Cordonnier C; de Pauw B; Durrant S; Marie JP; Moreau P; Guiot H; Samonis G; Sylvester R; Herbrecht R;
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4808-12. PubMed ID: 15561860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of invasive pulmonary aspergillosis in neutropenic patients by additional bronchoscopic amphotericin B instillation.
    Winkler J; Müller U; Nenoff P; Seyfarth HJ; Vogtmann M; Borte G; Pönisch W; Kahn T; Wirtz H; Schauer J; Hoheisel G
    Respiration; 2007; 74(6):663-73. PubMed ID: 17622755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis.
    Takazono T; Izumikawa K; Mihara T; Kosai K; Saijo T; Imamura Y; Miyazaki T; Seki M; Kakeya H; Yamamoto Y; Yanagihara K; Kohno S
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3508-10. PubMed ID: 19528281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
    Hoenigl M; Prattes J; Neumeister P; Wölfler A; Krause R
    Mycoses; 2018 Mar; 61(3):201-205. PubMed ID: 29112326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients.
    Bochennek K; Tramsen L; Schedler N; Becker M; Klingebiel T; Groll AH; Lehrnbecher T
    Clin Microbiol Infect; 2011 Dec; 17(12):1868-74. PubMed ID: 21895857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.